305 related articles for article (PubMed ID: 36618371)
1. The role of interferons in ovarian cancer progression: Hinderer or promoter?
Liu T; Li Y; Wang X; Yang X; Fu Y; Zheng Y; Gong H; He Z
Front Immunol; 2022; 13():1087620. PubMed ID: 36618371
[TBL] [Abstract][Full Text] [Related]
2. Double-edged effects of interferons on the regulation of cancer-immunity cycle.
Zhang X; Wang S; Zhu Y; Zhang M; Zhao Y; Yan Z; Wang Q; Li X
Oncoimmunology; 2021; 10(1):1929005. PubMed ID: 34262796
[TBL] [Abstract][Full Text] [Related]
3. Interferons: role in cancer therapy.
Abdolvahab MH; Darvishi B; Zarei M; Majidzadeh-A K; Farahmand L
Immunotherapy; 2020 Aug; 12(11):833-855. PubMed ID: 32635782
[TBL] [Abstract][Full Text] [Related]
4. Interferons and their stimulated genes in the tumor microenvironment.
Cheon H; Borden EC; Stark GR
Semin Oncol; 2014 Apr; 41(2):156-73. PubMed ID: 24787290
[TBL] [Abstract][Full Text] [Related]
5. Identification of immune microenvironment subtypes that predicted the prognosis of patients with ovarian cancer.
Wang X; Li X; Wang X
J Cell Mol Med; 2021 Apr; 25(8):4053-4061. PubMed ID: 33675171
[TBL] [Abstract][Full Text] [Related]
6. NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer.
Dong C; Yin F; Zhu D; Cai X; Chen C; Liu X
J Cell Biochem; 2020 Nov; 121(11):4470-4483. PubMed ID: 32030795
[TBL] [Abstract][Full Text] [Related]
7. Advances in the role of GPX3 in ovarian cancer (Review).
Geng D; Zhou Y; Wang M
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38299269
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer.
Gao L; Ying F; Cai J; Peng M; Xiao M; Sun S; Zeng Y; Xiong Z; Cai L; Gao R; Wang Z
J Ovarian Res; 2023 Jan; 16(1):27. PubMed ID: 36707884
[TBL] [Abstract][Full Text] [Related]
9. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
10. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
11. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.
Ding J; Wang C; Sun Y; Guo J; Liu S; Cheng Z
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830707
[TBL] [Abstract][Full Text] [Related]
12. Distribution and functions of γδ T cells infiltrated in the ovarian cancer microenvironment.
Chen X; Shang W; Xu R; Wu M; Zhang X; Huang P; Wang F; Pan S
J Transl Med; 2019 May; 17(1):144. PubMed ID: 31064389
[TBL] [Abstract][Full Text] [Related]
13. Interferons and cell growth control.
Kalvakolanu DV
Histol Histopathol; 2000 Apr; 15(2):523-37. PubMed ID: 10809374
[TBL] [Abstract][Full Text] [Related]
14. Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response.
von Locquenghien M; Rozalén C; Celià-Terrassa T
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33393507
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of immune microenvironment in ovarian cancer and its clinical significance: a retrospective study.
Gao Y; Chen L; Cai G; Xiong X; Wu Y; Ma D; Li SC; Gao Q
Oncoimmunology; 2020; 9(1):1760067. PubMed ID: 32391193
[TBL] [Abstract][Full Text] [Related]
16. Role of interferons (IFNs) in the differentiation of T peripheral helper (Tph) cells.
Tanemura S; Seki N; Tsujimoto H; Saito S; Kikuchi J; Sugahara K; Yoshimoto K; Suzuki K; Kaneko Y; Chiba K; Takeuchi T
Int Immunol; 2022 Sep; 34(10):533-544. PubMed ID: 35780437
[TBL] [Abstract][Full Text] [Related]
17. Modulating the tumor immune microenvironment with nanoparticles: A sword for improving the efficiency of ovarian cancer immunotherapy.
Xu T; Liu Z; Huang L; Jing J; Liu X
Front Immunol; 2022; 13():1057850. PubMed ID: 36532066
[TBL] [Abstract][Full Text] [Related]
18. Overexpressed COL5A1 is correlated with tumor progression, paclitaxel resistance, and tumor-infiltrating immune cells in ovarian cancer.
Zhang J; Zhang J; Wang F; Xu X; Li X; Guan W; Men T; Xu G
J Cell Physiol; 2021 Oct; 236(10):6907-6919. PubMed ID: 33655494
[TBL] [Abstract][Full Text] [Related]
19. Opportunities in immunotherapy of ovarian cancer.
Coukos G; Tanyi J; Kandalaft LE
Ann Oncol; 2016 Apr; 27 Suppl 1(Suppl 1):i11-i15. PubMed ID: 27141063
[TBL] [Abstract][Full Text] [Related]
20. Role of interferons and other cytokines in the regulation of the immune response.
Belardelli F
APMIS; 1995 Mar; 103(3):161-79. PubMed ID: 7538771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
